BOT 2.33% 21.0¢ botanix pharmaceuticals ltd

I agree in total Rusty. Management need to explain exactly what...

  1. 63 Posts.
    lightbulb Created with Sketch. 17
    I agree in total Rusty. Management need to explain exactly what occurred. To blame it on a startup is a joke. The specific reason must be divulged. Only then can the market make an informed decision instead of guesswork. We are entitled to this as shareholders. I will be asking this of management at the AGM. Id also like to know where the additional data analysis is for the psoriasis study. Psoriasis has dropped off the radar without explanation. Also the cbd and vehicle relative to the dermatitis study. Does it have the same issue that the US acne trial encountered. Was it sourced from the same manufacturer. Surely it was sourced at approximately the same time. I expect management to be transparent and diligent In response.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
21.0¢
Change
-0.005(2.33%)
Mkt cap ! $330.7M
Open High Low Value Volume
21.5¢ 22.0¢ 21.0¢ $376.0K 1.749M

Buyers (Bids)

No. Vol. Price($)
23 839196 21.0¢
 

Sellers (Offers)

Price($) Vol. No.
22.0¢ 376358 5
View Market Depth
Last trade - 16.10pm 26/04/2024 (20 minute delay) ?
Last
21.5¢
  Change
-0.005 ( 2.27 %)
Open High Low Volume
21.5¢ 22.0¢ 21.3¢ 737326
Last updated 15.57pm 26/04/2024 ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.